Joseph M. Miller

Insider Reports History

Entity
Individual
Location
C/O Cerecor Inc., 400 East Pratt Street, Suite 606, Baltimore, MD
Signature
/s/ Joseph M. Miller
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph M. Miller:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aurinia Pharmaceuticals Inc. Chief Financial Officer Common Stock 496K $2.78M $5.60 Mar 6, 2024 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 20.2K Mar 31, 2022 Direct

Insider Reports Filed by Joseph M. Miller

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AUPH Aurinia Pharmaceuticals Inc. Mar 6, 2024 1 -$195K 4 Mar 7, 2024 Chief Financial Officer
AUPH Aurinia Pharmaceuticals Inc. Feb 20, 2024 1 $0 4 Feb 22, 2024 Chief Financial Officer
AUPH Aurinia Pharmaceuticals Inc. Mar 2, 2023 1 -$100K 4/A Feb 22, 2024 Chief Financial Officer
AUPH Aurinia Pharmaceuticals Inc. Mar 2, 2023 2 -$101K 4 Mar 6, 2023 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 Director
AUPH Aurinia Pharmaceuticals Inc. Mar 2, 2022 4 -$36.8K 4 Mar 4, 2022 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Dec 31, 2021 1 $0 4 Jan 4, 2022 Director
AVTX Avalo Therapeutics, Inc. Sep 30, 2021 1 $0 4 Oct 4, 2021 Director
AVTX Cerecor Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
AVTX Cerecor Inc. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director
AUPH Aurinia Pharmaceuticals Inc. May 11, 2021 1 $9.74K 4 May 11, 2021 Chief Financial Officer